A coacervation-based microparticle encapsulation technology using FDA GRAS-approved polysaccharides and proteins to protect and deliver functional ingredients in beverages. The approach offers scalable production with tunable particle sizes (1–1000 µm), thermal and pH stability, and compatibility with diverse beverage matrices including milk, coffee, juices, and yogurt.
This research proposes a novel encapsulation technology designed to protect and deliver functional ingredients in beverages. Using the coacervation method with FDA GRAS-approved (Generally Recognized as Safe) biopolymers—both polysaccharide- and protein-based—the technology produces microparticles tailored to meet demanding beverage application requirements. The approach addresses key challenges in functional beverage formulation, including ingredient stability under thermal processing, pH variations, and long-term storage. By enabling controlled release and protection of sensitive bioactive compounds, this technology offers beverage manufacturers a scalable and food-safe pathway to incorporate health-promoting ingredients without compromising taste, texture, or shelf life.
Encapsulation method:
Material selection:
Characterization and analysis:
Development approach:
The technology is currently at an early-to-mid stage of development. The coacervation method itself is well-validated in the scientific literature, with multiple published studies demonstrating successful encapsulation of ingredients in beverage models. The research team is now advancing toward designing a proprietary complex coacervation system tailored to specific functional beverage ingredient requirements. Future validation steps include selecting optimal biopolymers, optimizing processing conditions, conducting comprehensive stability and rheological characterization, and producing a scalable protocol ready for industry adoption. This positions the technology for progression toward pilot-scale demonstration and eventual commercial licensing or co-development with beverage industry partners.
A leading public technical university anchored in Munich with campuses across Bavaria and a growing presence in Heilbronn, TUM pairs scale with an entrepreneurial culture. The Garching research campus co‑locates university labs with national institutes and start‑ups, while an integrated university hospital enables clinical translation. An Entrepreneurship Center with UnternehmerTUM and the TUM Venture Labs network link companies to prototyping, accelerators, and deep‑tech talent. Research draws competitive support from the German Research Foundation, federal ministries, Bavarian programs, and the European Union. TUM ForTe and its Patent & Licensing Office manage IP, streamline contracting, and offer a fast‑track model for startup licensing.